IVC Wealth Advisors LLC Has $411,000 Holdings in The Clorox Company (NYSE:CLX)

IVC Wealth Advisors LLC lessened its holdings in shares of The Clorox Company (NYSE:CLX) by 5.3% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 2,687 shares of the company’s stock after selling 150 shares during the period. IVC Wealth Advisors LLC’s holdings in Clorox were worth $411,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in the business. CIBC Private Wealth Group LLC lifted its position in shares of Clorox by 0.5% during the 4th quarter. CIBC Private Wealth Group LLC now owns 13,900 shares of the company’s stock worth $1,982,000 after purchasing an additional 66 shares during the last quarter. First National Bank of Mount Dora Trust Investment Services raised its holdings in Clorox by 3.2% in the 4th quarter. First National Bank of Mount Dora Trust Investment Services now owns 2,257 shares of the company’s stock valued at $322,000 after acquiring an additional 71 shares in the last quarter. Modera Wealth Management LLC raised its holdings in Clorox by 1.4% in the 3rd quarter. Modera Wealth Management LLC now owns 5,130 shares of the company’s stock valued at $672,000 after acquiring an additional 71 shares in the last quarter. Czech National Bank raised its holdings in Clorox by 0.3% in the 4th quarter. Czech National Bank now owns 21,718 shares of the company’s stock valued at $3,097,000 after acquiring an additional 71 shares in the last quarter. Finally, Global Retirement Partners LLC raised its holdings in Clorox by 7.2% in the 4th quarter. Global Retirement Partners LLC now owns 1,089 shares of the company’s stock valued at $156,000 after acquiring an additional 73 shares in the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

Analyst Upgrades and Downgrades

CLX has been the subject of several recent research reports. Deutsche Bank Aktiengesellschaft cut their price target on Clorox from $155.00 to $151.00 and set a “hold” rating for the company in a report on Wednesday, April 17th. Morgan Stanley reiterated an “equal weight” rating and issued a $160.00 price objective on shares of Clorox in a research note on Tuesday, March 26th. Evercore ISI lowered their price objective on Clorox from $145.00 to $142.00 and set an “underperform” rating on the stock in a research note on Wednesday, May 1st. BNP Paribas began coverage on Clorox in a research note on Monday, June 24th. They issued an “underperform” rating and a $130.00 price objective on the stock. Finally, UBS Group lowered their price objective on Clorox from $164.00 to $159.00 and set a “neutral” rating on the stock in a research note on Wednesday, May 1st. Five investment analysts have rated the stock with a sell rating and fourteen have assigned a hold rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $145.33.

Clorox Trading Down 0.7 %

NYSE:CLX traded down $0.99 during trading hours on Wednesday, hitting $132.56. 548,521 shares of the stock were exchanged, compared to its average volume of 1,254,351. The company’s 50 day moving average is $136.49 and its two-hundred day moving average is $143.67. The company has a quick ratio of 0.53, a current ratio of 0.90 and a debt-to-equity ratio of 9.73. The company has a market capitalization of $16.46 billion, a P/E ratio of 68.68, a price-to-earnings-growth ratio of 2.19 and a beta of 0.39. The Clorox Company has a twelve month low of $114.68 and a twelve month high of $169.14.

Clorox (NYSE:CLX) last posted its quarterly earnings results on Tuesday, April 30th. The company reported $1.71 earnings per share for the quarter, beating analysts’ consensus estimates of $1.33 by $0.38. The company had revenue of $1.81 billion for the quarter, compared to the consensus estimate of $1.87 billion. Clorox had a return on equity of 302.49% and a net margin of 3.33%. The firm’s quarterly revenue was down 5.3% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.51 EPS. On average, sell-side analysts anticipate that The Clorox Company will post 5.91 earnings per share for the current fiscal year.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.